Risk of Further Progression or Death Among Durable Progression-Free Survivors With Melanoma or Non-Small-Cell Lung Cancer in PD-1 Blockade Trials: Implications for Imaging Surveillance.

Deng, Lei; Jiang, Changchuan; Attwood, Kristopher; Zhao, Joseph J; Perimbeti, Stuthi; Hu, Chen; Puzanov, Igor; Dy, Grace K

Deng, Lei; Jiang, Changchuan; Attwood, Kristopher; Zhao, Joseph J; Perimbeti, Stuthi; Hu, Chen; Puzanov, Igor; Dy, Grace K.

Affiliation

Deng L; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Jiang C; Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA.
Attwood K; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Zhao JJ; Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Perimbeti S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Hu C; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Puzanov I; Division of Hematology and Oncology, Department of Medicine, The Pennsylvania State University, Hershey, PA.
Dy GK; Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.

JCO Oncol Pract ; 19(10): 871-881, 2023 Oct.

Article in En | MEDLINE | ID: mdl-37683137

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Melanoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: JCO Oncol Pract Year: 2023 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google